中国阿尔茨海默病蓝皮书(精简版)

Blue paper on Alzheimer′s disease in China(simplified version)

随着中国人口老龄化程度不断加重,阿尔茨海默病(AD)在我国的患病率和死亡率均不断上升,已成为严重危害人民群众健康和影响社会可持续发展的重大疾病之一。为响应健康中国行动,提高国民健康水平,促进健康发展,首都医科大学宣武医院国家神经疾病医学中心、中国疾病预防控制中心慢性非传染性疾病预防控制中心、国家卫生健康委能力建设和继续教育中心、中国人口与发展研究中心等单位专家和学者联合编写《中国阿尔茨海默病蓝皮书(精简版)》(简称蓝皮书)。蓝皮书系统回顾了目前中国AD及其他认知障碍疾病的流行病学特征、诊疗现状、防治管理等情况,旨在为人群AD疾病预防提供依据、为疾病规范化诊疗提供支持、为政府制定相关卫生政策提供参考。蓝皮书主要包括AD及其他认知障碍疾病的以下内容:(1)流行病学特征;(2)经济负担;(3)影响因素;(4)中国脑认知健康指数;(5)诊断现状;(6)治疗现状;(7)认知障碍诊疗中心建设;(8)社区防治;(9)AD患者的照料;(10)防治的公共卫生资源。

With the population aging in China,the prevalence and mortality rate of Alzheimer′s disease(AD)have been rising in China.AD has become one of the major threats to people′s health and social sustainable development.In order to support the Healthy China Initiative and promote health in China,"Chinese Alzheimer′s Disease Blue Book(Simplified Edition)"(refer to as the Blue Book)was compiled by experts and scholars from the National Center for Neurological Disorders,Xuanwu Hospital,Capital Medical University;the National Center for Chronic and Noncommunicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention;the National Health Commission Capacity Building and Continuing Education Center;and the China Population and Development Research Center.The epidemiological characteristics,diagnosis and treatment status,prevention and treatment management of AD and related cognitive disorders in China were systematically reviewed in the Blue Paper,aiming to provide references for the prevention of AD,provide support for the standardized diagnosis and treatment of the disease,and provide a reference for the government to formulate relevant health policies.Specifically,the Blue Book covers the following topics of AD and related cognitive disorders:(1)epidemiology characteristics;(2)economic burden;(3)influencing factors;(4)China Brain Cognitive Health Index;(5)diagnosis status;(6)treatment status;(7)construction of national center for cognitive disorders;(8)community-based prevention and control;(9)AD patients care;(10)public health resources for prevention and control.